| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HENRY SCHEIN INC | Director | Common Stock, par value $0.01 per share | 12,520 | $942,255 | $75.26 | 06 Mar 2026 | Direct |
| Adverum Biotechnologies, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct | ||
| CTI BIOPHARMA CORP | Director | Common Stock | 0 | $9.10 | 26 Jun 2023 | Direct | |
| CTI BIOPHARMA CORP | Director | Stock Option (Right to Buy) | 0 | 26 Jun 2023 | Direct |